Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Tourniquet-Induced Effects in TKA
NCT04307290Phase 4Completed
- Sponsor
- Wonkwang University Hospital
- Start
- Feb 2020
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in ischemia-reperfusion injury (IRI), sponsored by Wonkwang University Hospital. Started Feb 2020; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT04307290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04307290.